Početna › Lupusni nefritis › Texas
Kliničke studije za Lupusni nefritis u državi Texas
12 studija za Lupusni nefritis traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Prolato Clinical Research Center, Houston
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05268289Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Baylor College of Medicine, Houston
U tijeku regrutacijaFaza 1
Od 18 do 60 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
U tijeku regrutacijaFaza 2
Od 8 do 20 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- The University of Texas Southwestern Medical Center, Dallas
U tijeku regrutacijaFaza 2
Od 12 do 70 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07570862RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Texas MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Texas Transplant Institute, San Antonio
U tijeku regrutacijaFaza 2
Od 12 do 65 godina · Oba spola · Ažurirano 24. kol 2026. · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Novel Research LLC, Bellaire
- Liberty Research Center, Dallas
- Texas Arthritis Center, El Paso
- i još 5
U tijeku regrutacijaFaza 4
Od 18 do 75 godina · Oba spola · Ažurirano 3. kol 2026. · NCT07611214A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Rheumatology Care Center, PLLC, Bellaire
- Texas Arthritis Center, El Paso
- Novel Research, LLC., Houston
- i još 3
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07201129A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
U tijeku regrutacijaFaza 1/2
Od 18 do 75 godina · Oba spola · Ažurirano 4. lip 2026. · NCT06557265Lupus Landmark Study: A Prospective Registry and Biorepository
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 15. tra 2026. · NCT05934149Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 15. tra 2026. · NCT06434363Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- AARA Clinical Research, Fort Worth
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 6. stu 2025. · NCT07225387Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.